Wesley A. Cheng

459 total citations
17 papers, 270 citations indexed

About

Wesley A. Cheng is a scholar working on Infectious Diseases, Oncology and Molecular Biology. According to data from OpenAlex, Wesley A. Cheng has authored 17 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Wesley A. Cheng's work include SARS-CoV-2 and COVID-19 Research (7 papers), CAR-T cell therapy research (6 papers) and COVID-19 Clinical Research Studies (3 papers). Wesley A. Cheng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), CAR-T cell therapy research (6 papers) and COVID-19 Clinical Research Studies (3 papers). Wesley A. Cheng collaborates with scholars based in United States, China and Japan. Wesley A. Cheng's co-authors include Hong Qin, Larry W. Kwak, Zhenyuan Dong, D. Lynne Smith, Guo‐Wei Wei, Han Sun, Pia S. Pannaraj, Yijun Liu, Soung-Chul Cha and Jacob E. Montgomery and has published in prestigious journals such as Blood, PLoS ONE and PEDIATRICS.

In The Last Decade

Wesley A. Cheng

17 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wesley A. Cheng United States	9	117	100	47	46	35	17	270
Anyu Bao China	13	34 0.3×	48 0.5×	20 0.4×	117 2.5×	28 0.8×	24	349
Giovanna Donvito Italy	4	48 0.4×	127 1.3×	27 0.6×	169 3.7×	6 0.2×	4	367
Laura Dunn United States	6	83 0.7×	160 1.6×	23 0.5×	57 1.2×	9 0.3×	8	318
Anna Torrent Spain	11	108 0.9×	93 0.9×	11 0.2×	92 2.0×	41 1.2×	40	393
Cecilia Hellström Sweden	11	19 0.2×	69 0.7×	77 1.6×	95 2.1×	5 0.1×	16	317
Juan Navarro‐Barriuso Spain	12	62 0.5×	280 2.8×	32 0.7×	107 2.3×	5 0.1×	15	402
Neha Singh India	10	41 0.4×	43 0.4×	8 0.2×	56 1.2×	56 1.6×	30	231
Zi‐Xuan Wang United States	11	80 0.7×	45 0.5×	220 4.7×	139 3.0×	7 0.2×	13	500
Yanling Liang China	11	75 0.6×	129 1.3×	33 0.7×	89 1.9×	4 0.1×	29	323
Nora Lam United States	7	49 0.4×	158 1.6×	18 0.4×	76 1.7×	4 0.1×	8	333

Countries citing papers authored by Wesley A. Cheng

Since Specialization

Citations

This map shows the geographic impact of Wesley A. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wesley A. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wesley A. Cheng more than expected).

Fields of papers citing papers by Wesley A. Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wesley A. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wesley A. Cheng. The network helps show where Wesley A. Cheng may publish in the future.

Co-authorship network of co-authors of Wesley A. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wesley A. Cheng. A scholar is included among the top collaborators of Wesley A. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wesley A. Cheng. Wesley A. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Cheng, Wesley A., et al.. (2024). Detection of SARS-CoV-2-Specific Secretory IgA and Neutralizing Antibodies in the Nasal Secretions of Exposed Seronegative Individuals. Viruses. 16(6). 852–852. 2 indexed citations

Cheng, Wesley A., Lauren Turner, Jaycee Jumarang, et al.. (2023). Comparisons of Pediatric and Adult SARS-CoV-2-Specific Antibodies up to 6 Months after Infection, Vaccination, or Hybrid Immunity. Journal of the Pediatric Infectious Diseases Society. 13(1). 91–99. 4 indexed citations

Kim, Minjun, Aaron Sutherland, Jaycee Jumarang, et al.. (2023). Effect of wash media type during PBMC isolation on downstream characterization of SARS-CoV-2-specific T cells. Journal of Immunological Methods. 519. 113520–113520. 1 indexed citations

Cheng, Wesley A., Lauren Turner, Jaycee Jumarang, et al.. (2022). Twelve-Month Longitudinal Serology in SARS-CoV-2 Naïve and Experienced Vaccine Recipients and Unvaccinated COVID-19-Infected Individuals. Vaccines. 10(5). 813–813. 9 indexed citations

Bender, Jeffrey M., et al.. (2022). Coronavirus Disease 2019 Vaccine Booster Effects Are Seen in Human Milk Antibody Response. Frontiers in Nutrition. 9. 898849–898849. 12 indexed citations

Wang, Xiuli, Zhenyuan Dong, Dennis Awuah, et al.. (2022). CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia. Leukemia. 36(4). 1015–1024. 27 indexed citations

Cheng, Wesley A., et al.. (2022). Human Milk SARS-CoV-2 Antibodies up to 6 Months After Vaccination. PEDIATRICS. 149(2). 31 indexed citations

Cheng, Wesley A., et al.. (2021). Clinical manifestations of COVID‐19 differ by age and obesity status. Influenza and Other Respiratory Viruses. 16(2). 255–264. 17 indexed citations

Wang, Xiuli, Zhenyuan Dong, Wen-Chung Chang, et al.. (2021). CD19/BAFF-R Dual-Targeted CAR T Cells for the Treatment of Mixed Antigen-Negative Variants of Acute Lymphoblastic Leukemia. Blood. 138(Supplement 1). 2783–2783. 3 indexed citations

10.

Dong, Zhenyuan, Wesley A. Cheng, D. Lynne Smith, et al.. (2020). Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions. Cancer Immunology Immunotherapy. 69(10). 2139–2145. 17 indexed citations

11.

Cheng, Wesley A.. (2019). Measuring the Robustness of the National Basketball Association Home Court Advantage Effect. eScholarship (California Digital Library). 1 indexed citations

12.

Qin, Hong, Zhenyuan Dong, Xiuli Wang, et al.. (2019). Overcoming CD19 Antigen Loss in B-Cell Malignancies with CAR T Cells Targeting BAFF-R. Blood. 134(Supplement_1). 3871–3871. 1 indexed citations

13.

Liu, Yijun, Guo‐Wei Wei, Wesley A. Cheng, et al.. (2018). Targeting myeloid-derived suppressor cells for cancer immunotherapy. Cancer Immunology Immunotherapy. 67(8). 1181–1195. 91 indexed citations

14.

Qin, Hong, Guo‐Wei Wei, Ippei Sakamaki, et al.. (2017). Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo. Clinical Cancer Research. 24(5). 1114–1123. 24 indexed citations

15.

Qin, Hong, Zhenyuan Dong, Wesley A. Cheng, et al.. (2017). CAR-T Cells Targeting BAFF-Receptor for B-Cell Malignancies: A Potential Alternative to CD19. Blood. 130. 3180–3180. 2 indexed citations

16.

Qin, Hong, Guo‐Wei Wei, Ippei Sakamaki, et al.. (2016). Novel BAFF-Receptor Antibody to Natively Folded and Glycosylated Recombinant Protein Eliminates Drug Resistant B Cell Malignancies In Vivo. Blood. 128(22). 468–468. 1 indexed citations

17.

Li, Xinle, Jacob E. Montgomery, Wesley A. Cheng, et al.. (2012). Pineal Photoreceptor Cells Are Required for Maintaining the Circadian Rhythms of Behavioral Visual Sensitivity in Zebrafish. PLoS ONE. 7(7). e40508–e40508. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact